The development of LDCT screening for lung cancer was a significant advance; there are patient populations that were not included in the original studies.

Use of tobacco products, marijuana, opioids, herbal supplements and illicit substances is quite common and can have significant impact on safety and efficacy of cancer treatments and pain tolerance.

With the increasing use of cancer immunotherapies for a variety of cancers, including lung cancer, there has been a parallel increase in the toxicity profile across organ systems.

There have been many advances in the systemic therapy for lung cancer. Novel agents carry with them unique toxicities and considerations for multidisciplinary cancer care.

The Cancer Breakthroughs activity brings together several medical societies in a collaborative effort to provide a summary of this year’s groundbreaking cancer studies.

This course is designed to provide clinicians in practice and trainees with a comprehensive review and update of the clinical practice parameters across most major sub-disciplines of radiation oncology, including sarcomas, pediatrics and lymphomas, and the role of radiotherapy in the multidiscipl

2023 Annual Meeting

 

The 2024 Multidisciplinary Head and Neck Cancers Symposium is a two-and-a-half-day meeting featuring interactive and case-based educational sessions that cover new multidisciplinary therapies, imaging, immunotherapy, treatment guidelines, supportive care and understanding disparities in head and

Immunotherapy has become standard of care for all stages of NSCLC. However, there is a gap in knowledge on how to select patients for neoadjuvant immunotherapy followed by surgical resection.

The 2023 Multidisciplinary Thoracic Cancers Symposium features case discussions; educational sessions on multidisciplinary therapies, new targeted therapies, immunotherapy, treatment and screening guidelines, supportive care; and oral abstract sessions highlighting the most current, evidence-base

Pages

Subscribe to RSS - onDemand Meeting